Consistently, in the SEQC‐RPM‐seqcnb1 dataset, high DDX21 (Fig. 6G) or CEP55 (Fig. 6H) mRNA expression in the subset of 92 MYCN‐amplified neuroblastoma patients also correlated with poorer patient survival. This evidence concerns the gene MYCN and neuroblastoma.